IsoPlexis Corporation
ISO · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $3 | $4 | $4 | $5 |
| % Growth | -25% | 12% | -18.4% | – |
| Cost of Goods Sold | $11 | $2 | $2 | $2 |
| Gross Profit | -$8 | $2 | $2 | $3 |
| % Margin | -232.5% | 50.3% | 51.8% | 52% |
| R&D Expenses | $5 | $4 | $7 | $7 |
| G&A Expenses | $14 | $9 | $8 | $11 |
| SG&A Expenses | $19 | $14 | $16 | $24 |
| Sales & Mktg Exp. | $5 | $6 | $7 | $12 |
| Other Operating Expenses | -$0 | $0 | -$0 | -$0 |
| Operating Expenses | $24 | $19 | $23 | $30 |
| Operating Income | -$32 | -$16 | -$21 | -$28 |
| % Margin | -945.8% | -365.7% | -515.6% | -564.9% |
| Other Income/Exp. Net | -$1 | -$1 | -$5 | -$1 |
| Pre-Tax Income | -$33 | -$18 | -$26 | -$29 |
| Tax Expense | $2 | $1 | $1 | $1 |
| Net Income | -$35 | -$20 | -$27 | -$30 |
| % Margin | -1,033% | -444.7% | -670.2% | -605% |
| EPS | -0.88 | -0.51 | -0.69 | -0.76 |
| % Growth | -72.5% | 26.1% | 9.2% | – |
| EPS Diluted | -0.88 | -0.51 | -0.69 | -0.76 |
| Weighted Avg Shares Out | 39 | 39 | 39 | 39 |
| Weighted Avg Shares Out Dil | 39 | 39 | 39 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$31 | -$15 | -$19 | -$26 |
| % Margin | -911.7% | -335.9% | -484.5% | -538.3% |